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The outcome of 1,102 patients referred for cardiac trans-
plantation at five centers participating in the National
Heart Transplantation Study was examined. Using med-
ical and referral records, patients were tracked from
date of referral until they were rejected as transplan-
tation candidates or receiveda transplant. Overall, 34.6%
of all patients referred were eventually accepted for
transplantation but, of these, 71.9% underwent the pro-
cedure. Of those patients accepted but not undergoing
the procedure, the vast majority (58.8%) died awaiting
a donor heart; another 30.8% later refused the proce-
dure. Very few patients (2.1%) who were accepted for
transplantation were deselected as possible candidates
The rapid proliferation of cardiac transplantation centers
across the United States and a concomitant increase in the
total number of cardiac transplantation procedures per-
formed annually have spurred renewed concern about the
selection of transplantation candidates and the supply of
donor hearts (1-7). With respect to patient selection. new
cardiac transplantation programs. out of concern about their
trial status, appear to be carefully screening patients, choos-
ing candidates that are most likely to survive their surgery
and have a relatively uneventful postoperative course. This
is prudent as the continuation of such programs often de-
pends on their short-term success. However, established
transplantation programs, based on their long-term success,
have begun to relax their patient selection criteria and now
accept patients they would have previously rejected. Clearly,
patient selection criteria are changing and this , coupled with
the remarkable increase in the number of active cardiac
transplantation programs, has made access to donor hearts
very competitive (3,7). Ultimately it appears that both the
availability and success of cardiac transplantation will de-
pend on careful patient selection.
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because of improved health status. The number of pa-
tients awaiting transplantation at all centers was found
to be small at the time of study.
The results of the analyses revealed major differences
among centers in evaluation procedures, proportion of
patients accepted and number of patients receiving a
transplant. For example, one center performed trans-
plantation on only50.0% of all patients it accepted, while
another did so in more than 81.0% of such patients. It
is concluded that both patient selection and donor supply
will remain significant determinants of the outcome of
patients referred for cardiac transplantation.
(J Am Coli Cardiol 1986;8:1312-7)
Based on the foregoing , it would therefore seem to be
of some value to carefully examine the patient selection
experience of several major cardiac transplantation pro-
grams in the United States. The National Heart Transplan-
tation Study , a multicenter observational study of 441 car-
diac transplant recipients and 1,102 patients referred for
cardiac transplantation, provides a unique data base to ad-
dress the patient selection problem (1,8) .
Methods
Study design. The National Heart Transplantation Study
is a retrospective study of patients formally referred for
cardiac transplantation, those accepted as candidates for
transplantation and those who eventually underwent the pro-
cedure (1). Six transplantation centers participated in this 4
year study funded by the Health Care Financing Adminis-
tration (9). They included the Arizona Health Sciences Cen-
ter (Tucson, Arizona), Columbia Presbyterian Hospital and
Medical Center (New York, New York), the Medical Col-
lege of Virginia (Richmond, Virginia) , the University of
Pittsburgh (Pittsburgh, Pennsylvania) , the University of
Minnesota (Minneapolis , Minnesota), and the Stanford Uni-
versity Medical Center (Stanford , California) (10-13). The
primary objective of the study was to collect and analyze
those data required to enable the Health Care Financing
Administration to determine whether Medicare benefits should
be extended to cover cardiac transplantation (9).
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The medical records of all patients (n = 441) undergoing
cardiac transplantation at the six participating centers be-
tween January I, 1968 and June 30, 1983, as well as the
records for all patients (n = 1,102) referred to these centers
between January I, 1978 and June 30, 1983, were carefully
reviewed, except for the records of those patients who re-
fused to provide written consent for the collection of these
data or deceased patients whose next of kin refused per-
mission (1). Separate data collection forms were completed
for the recipients and nonrecipients of a heart transplant.
A Transplantation Recipient Medical and Hospital Rec-
ords Data Abstraction Form was completed for two patient
groups: 1) patients accepted as candidates for cardiac trans-
plantation who received a heart transplant and were living;
and 2) patients accepted as cardiac transplantation candi-
dates who received a heart transplant and were deceased.
Because there are other cardiac transplantation programs in
the United States, the patients at the six centers that partic-
ipated in the study did not constitute the universe of all heart
transplant recipients. However, in 1983 these six programs
performed 80.2% of all cardiac transplantations in the United
States. Because data were unavailable for patients referred
earlier than 1978, only data for the 274 transplantation pa-
tients contemporaneous with the referred patients are in-
cluded in this analysis. Also, 21 patients receiving a second
or third transplant were omitted.
A Nonrecipient Medical and Hospital Records Data Ab-
straction Form was completed for all patients formally re-
ferred but who did not receive a heart transplant within the
time period specified. This included patients in the following
groups: I) patients who were formally referred for trans-
plantation but for whom there was no decision or further
contact; 2) patients who were referred or evaluated for trans-
plantation but died before a decision was made; 3) patients
turned down as suitable candidates for a heart transplant;
4) patients who were accepted as heart transplantation can-
didates but died before receiving one; 5) patients who were
accepted as heart transplantation candidates but were later
deselected; 6) patients who were accepted as heart trans-
plantation candidates but were still awaiting the identifi-
cation of a suitable donor; and 7) patients who were accepted
as heart transplantation candidates but did not receive the
procedure by the patient's choice.
Patient referral. An understanding of the process by
which patients are referred to cardiac transplantation pro-
grams is essential to understanding the information con-
tained in the two Medical and Hospital Records Data Ab-
straction Forms. Patients can be referred to a transplantation
program in one of several ways and their evaluations may
vary in extent. In some instances a referring cardiologist
will call the transplantation program and describe the details
of a patient's case. On the basis of this information, the
transplantation program may tum the patient down as a
possible candidate or may request that additional informa-
tion be sent for further consideration. Most transplantation
programs do not keep records on simple telephone inquiries.
If, however, the results of tests and evaluations are sent
(what we are calling "formal referral "), the program will
usually start a file. Forms were returned to the National
Heart Transplantation Study coordinating center for all pa-
tients with an existing file.
After receiving materials from the referring cardiologist,
the program then decides whether or not the patient should
have a complete cardiac evaluation. This evaluation is sim-
ilar for both cardiac transplantation and other major cardiac
surgery. In addition to a history and physical examination
it generally includes: 1) radiologic and hemodynamic eval-
uation, 2) hemotologic studies, 3) biochemical studies and
4) several tests for bacterial, viral and fungal infections. In
some cases transplantation teams make a determination-
either positive or negative-without performing such tests
at the center. When a complete evaluation is performed at
the center, a decision is made to accept or reject the patient
as an official transplantation candidate based on the results
of the evaluation.
Patient selection. At the time the National Heart Trans-
plantation Study data were collected, most transplantation
centers followed what were generally referred to as the
"Stanford criteria" (14-19). These criteria (Table 1) evolved
over time and were carefully delineated by special consul-
tants to the National Heart, Lung, and Blood Institute (I).
The criteria were developed as guidelines for the selection
of prospective cardiac transplantation candidates during the
course of the study.
Strict patient selection protocols are currently followed
by the vast majority of programs to select transplantation
candidates (16). Generally, these are designed to achieve
the highest possible rate of successful treatment outcomes.
These protocols weigh the nature of the cardiovascular prob-
lem, the presence of other medical problems, the age of the
candidate, the psychologic and possibly the financial status
of the patient.
At the present time, no formal policy exists regarding
the selection ofcandidates for cardiac transplantation. Nei-
ther the federal government nor medical professional groups
have explicitly mandated a list of specific patient selection
criteria. Each transplantation program has remained free to
develop its own methods and criteria for selecting heart
transplant candidates. As noted, however, there is remark-
able similarity among the patient selection criteria of cardiac
transplantation programs in the United States and abroad
(17-20).
Potential heart transplant recipients are generally as-
sessed according to a protocol similar to that followed at
Stanford (21). The assessment is made by a group that
includes a cardiologist, social worker, and cardiac surgeon,
all of whom have significant responsibility for direct patient
care. Typically, at Stanford, the group accepts a number of
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Table 1. Contraindications to Cardiac Transplantation As Specified By The National Heart, Lung, and Blood Institute Special
Advisory Committee
I) Advancing age-for example, beyond the age (normally about 50 years) at which the individual begins to have diminished capacity to withstand
postoperative complications
2) Severe pulmonary hypertension as reflected, for example, by a pulmonary artery systolic pressure over 65 to 70 mm Hg and exceeding pulmonary
artery wedge pressure by about 40 or more mm Hg, or a calculated pulmonary vascular resistance above approximately 6 Wood units (applicable
to orthotopic cardiac transplantation because of the limited work capacity of a normal donor right ventricle)
3) Irreversible and severe hepatic or renal dysfunction (because of the likelihood of exacerbation early postoperatively and because of interference
with immunosuppressive regimens)
4) Active systemic infection (because of the likelihood of exacerbation with initiation of immunosuppression)
5) Any other systemic disease considered likely to limit or preclude survival and rehabilitation after transplantation
6) A history of behavior pattern or psychiatric illness likely to interfere significantly with compliance with a disciplined medical regimen (because a
lifelong medical regimen is necessary, requiring multiple drugs several times a day with serious consequences in the event of their interruption or
excessive consumption)
7) Recent and unresolved pulmonary infarction or pulmonary roentgenographic evidence of abnormalities of unclear etiology (because of the likelihood
of pulmonary infection or its exacerbation with initiation of immunosuppression under such circumstances)
8) Insulin-requiring diabetes mellitus (because of exacerbation by chronic corticosteroid therapy)
9) Symptomatic or documented severe asymptomatic peripheral or cerebrovascular disease (because of observed accelerated progression in some
patients after cardiac transplantation and on chronic corticosteroid treatment)
10) Acute peptic ulcer disease (because of the likelihood of early postoperative exacerbation)
II) The absence of adequate external psychosocial supports for either short- or long-term bases (because such support is generally necessary during
the inevitable waxing and waning of the clinical status of the patient and for adherence to the lifelong medical regimen).
Source: See reference 9, pages 7072-4.
patients roughly equal to the number of transplantations that
can be performed in any given period (21). While they are
not labeled as such, the eligibility standards of the program
seem to be that: I) the patient have a critical medical need
for the transplantation, 2) there be no alternative medical
or surgical means that will allow greater survival, and 3)
the procedure has a reasonable chance of successful outcome
given the current state of transplantation technology.
Definition of terms. The ultimate disposition of patients
referred to cardiac transplantation programs is sufficiently
complex that special decision-descriptors are required to
distinguish among the variety of possible patient outcomes.
For purposes of the study, this was accomplished in a rel-
atively straightforward manner. For the most part, as dis-
cussed below, the descriptors are self-evident.
I) No decision. A decision is not always reached when
a patient referral occurs. The patient may die before the
evaluation is complete or withdraw from further consider-
ation. Also, in some instances, it becomes impossible to
advise the patient of his disposition.
2) Decision without formal in-center evaluation. Some
patients who are accepted or rejected may not come to the
transplantation center for evaluation. Sufficient knowledge
necessary for a decision may be gained from evaluations
conducted elsewhere than the transplantation center, or may
be based, in part, on other information submitted by the
referring physician. In most cases this information permits
the center to reject the patient without further in-center ex-
amination.
3) Evaluated at least overnight. Some evaluations take
place at the center, but on an outpatient basis, but most in-
center evaluations involved a stay of several days. Because
these provide the fullest information, it was thought best to
distinguish them as a separate group.
4) Accepted. The term accepted is applied to any patient
who is ultimately declared a candidate for cardiac trans-
plantation.
5) Rejected. A patient who fails to qualify as a cardiac
transplantation candidate is considered "rejected."
6) Accepted but transplantation not performed. Not all
patients who are accepted for cardiac transplantation undergo
the procedure. The majority of such patients will die await-
ing a donor heart. Another group of patients may decide
against proceeding with cardiac transplantation and there-
fore refuse to have it. A very small number of patients
eventually are deselected because they develop contrain-
dications or their health status and prognosis for survival
improves. The latter group of patients are often later de-
clared candidates for cardiac transplantation a second time.
Finally, at the close of the data collection period for the
NHTS some patients were actually on the waiting list await-
ing the availability of a donor heart.
7) Transplantation. Patients who actually undergo a car-
diac transplantation are said to have had a transplant.
Statistical analysis. Simple descriptive data are pre-
sented here consisting of percent distributions of patients.
Actual numbers of patients are also presented because of
the small number of patients that are contained in some
subcategories within the table.
Results
Table 2 presents the number and percent distribution of
patients formally referred for cardiac transplantation ac-
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Table 2. Number and Percent Distribution of Prospective Heart Transplant Patients Who Are Rejected, Accepted and Undergo
Transplantation at Five Cardiac Transplant Centers 1978 to 1983
Arizona Columbia MCV Pittsburgh Stanford Total
Total Referred 98 78 173 94 659 1,102
No. % No. % No. % No. % No. % No. %
No decision 22 22.4 0 0.0 55 31.8 8 8.5 177 26.8 262 23.8
Died before evaluation complete 13 13.3 0 0.0 39 22.5 I 1.1 71 10.8 124 11.2
No further contact or patient went 9 9.2 0 0.0 16 9.2 7 7.4 106 16.1 138 12.5
elsewhere
Decision without formal evaluation 24 24.2 3 4.8 5 32.9 21 22.3 255 38.7 360 32.7
Rejected 18 18.2 0 0.0 52 30.0 10 10.6 215 32.6 295 26.8
Accepted 6 6.1 3 3.8 5 2.9 II 11.7 40 6.1 65 5.9
Evaluated at least overnight 52 53.1 75 96.2 61 35.3 65 69.1 227 34.4 480 43.6
Rejected 10 10.2 28 35.9 21 12.1 II 11.7 94 14.3 164 14.9
Accepted 42 42.8 47 60.2 40 23.1 54 57.4 133 20.2 316 28.7
Total accepted 48 49.0 50 64.1 45 26.0 65 69.1 173 26.2 381 34.6
First percentage given is of all referred patients/second percentage is of all accepted patients.
Accepted but not undergoing transplantation 9 9.2118.8 25 32.0/50.0 10 5.8/22.2 16 17.0/24.6 47 7.1/27.2 107 9.7/28.1
Died waiting 6 6.1112.5 II 14.1/22.0 4 2.3/8.9 19 9.6/13.8 33 5.0119.1 63 9.7116.5
Refused a transplant 2 2.0/4.2 10 12.8/20.0 6 3.5/13.3 5 5.3/7.7 10 1.5/5.8 33 3.0/8.7
Deselected I 1.0/2.1 3 3.8/6.0 0 0.0/0.0 2 2.1/3.1 2 0.3/1.2 8 0.7/2.1
Waiting (at the time of survey) 0 0.0/0.0 I 1.3/2.0 0 0.0/0.0 0 0.0/0.0 2 0.3/1.2 3 0.3/0.8
Undergoing transplantation 39 39.8/81.2 25 31.0/50.0 35 20.2/77.8 49 52.1175.4 126 19.1/72.8 274 24.9171.9
MCV = Medical College of Virginia.
cording to their final outcome. The University of Minnesota
is excluded from this table because data were not provided
on patient referrals. In Table 2, during the period for which
data were collected, nearly 60% of all patients (659 of
1,102) were referred to Stanford, followed by the Medical
College of Virginia, which received 16% of the referrals
analyzed here. The referral experience of Arizona, Colum-
bia and Pittsburgh, all programs that began about the same
time, is similar.
Patient referral process. The Medical College of Vir-
ginia had the largest percentage of patients for whom no
decision was reached (31. 8%), and Columbia the lowest
(0%). Overall, in 23.8% of the cases considered, no decision
was reached because I) the patient died or withdrew, or 2)
the transplantation center was unable to establish further
contact. Patients were approximately evenly distributed be-
tween these two groups. Among the total of those who
ultimately received a transplant and those who did not,
approximately 50 were reported to have had a "previous
evaluation" at another center, although the extent of this
evaluation was not specified. Of these, 16 were accepted
into the program that submitted their data to the study. Eight
reportedly went to another center, although their disposition
is unknown. Twenty-four were rejected or died during their
(second) evaluation. Only 35 of the 50 with previous eval-
uations had these experiences at other centers in the study.
It is possible that they were included in the table twice;
however, this would be appropriate in order to document
their full experience.
Stanford clearly is much more likely to decide whether
it will accept a patient without formal evaluation. In 38.7%
of the cases this occurred, with the majority of patients
rejected. Columbia, on the other hand, decided the status
of only three patients (all of them accepted) in the absence
of a formal evaluation. Overall, about one third of all pa-
tients referred for cardiac transplantation are accepted or
rejected without formal evaluation.
Centers differ markedly in the intensity of the evaluation
process (Table 2). At Columbia, 96.2% of all patients re-
ferred are evaluated at least overnight. Of these patients,
about 63% are ultimately accepted. Both the Medical Col-
lege of Virginia and Stanford admit about one third of their
patients for overnight evaluation. Overall, 43.6% of all pa-
tients referred for cardiac transplantation must spend at least
one night undergoing evaluation. Of these, 65.8% are ac-
cepted.
Outcome of patient evaluation. Of the 1,102 patients
referred to the five centers providing referral data, 381 (34.6%)
were accepted for cardiac transplantation. Most (82.9%)
were evaluated overnight. The two lower panels of Table
2 show the outcomes of all accepted patients. In both of
these it is meaningful to give percentages of all referred
patients (n = 1,102) and of all accepted patients (n = 381).
The 107 patients who were accepted for cardiac transplan-
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Table 3. Number of Transplant Recipients By Transplantation
Center With One or More Contraindications to
Cardiac Transplantation
of all patients referred , it performs transplantation on the
smallest proportion.
A number of variables in which centers may differ were
not investigated here . These include I) the case mix of
patient referrals , 2) the supply of donor hearts, and 3) the
willingness of centers to perform transplantation on patient s
with recognized contraindications. It is quite possible that
the case mix of patients referred to each center differs mark-
edly. For example, on the one hand, older established pro-
grams such as Stanford and the Medical College of Virginia
may get a disproportionate share of severely ill patients
referred to them because of their experience. Newer pro-
grams, on the other hand, may have a more favorable re-
ferral case mix. Additional analy ses are required to further
delineate the nature of the case mix problem.
The percentage of patients that undergo transplantation
is in large part a function of donor supply and, as already
noted, donor supply problems are more acute in some areas
of the country than in others (3). It is, nonetheless, rather
remarkable that just over 70% of all patients accepted for
cardiac transplantation eventually undergo the procedure.
Despite the recent variation in selection criteria, it is
evident, however, that all centers uniformly follow the se-
lection criteria provided in Table I , as very few patients
who receive a transplant have recognized contraindications.
Table 3 shows the number and percent distribution of pa-
tients with contraindications by center.
Proliferation of centers. With the rapid diffusion of
cardiac transplantation programs across the United States,
from 14 programs in 1983 to more than 80 today, it is very
likely that a larger number of patients will be referred for
transplantation (22-24). Also , because of the high level of
success now associated with cardiac transplantation (for ex-
ample, more than 25% of all patients will live 10 years or
longer), it is quite possible that patient selection criteria will
be relaxed in an effort to help more patients (26-28) . How-
ever, a larger number of transplantation centers, increased
patient referrals and improved transplantation success rates
will further strain an already limited supply of donor hearts,
estimated to be between 500 and 1,300 per year (7) . To
ensure the continued success of cardiac transplantation , it
tation but who did not undergo the procedure constituted
9.7% of all patients referred and 28.1 % of all those ac-
cepted . Arizona clearly has the smalle st percentage of pa-
tients accepted but not receiving transplantation, and Co-
lumbia the highest. At Columbia 50% of all patients accepted
did not undergo transplantation compared with 18.8% at
Arizona. About 27% of accepted patient s at Stanford did
not undergo transplantation, which is close to the total for
all centers (28 . 1%) .
There are many reasons why accepted patients do not
undergo transplantation and , again, there are substantial
differences across centers. At all centers, except the Medical
College of Virginia, patients accepted but receiving a trans-
plant are most likely to die awaiting a donor heart. Overall
63 (59%) of 107 such patients died. Rather interestingly,
patients accepted at some centers, most notably Columbia,
ultimately turned down their chance to undergo a trans-
plantation. Overall 30 .8% (33 of 107) of accepted patients
who did not undergo transplantation refused the procedure,
though this is only 8.7 % of all patient s accepted (33 of 381) .
Very few patients were deselected and even fewer were on
waiting lists at the end of the data collection period . Also ,
there was little evidence of trends over the 5~ years in the
variou s categories. The percentage of accepted patients who
died annually while awaiting surgery decreased from 27 to
13% between 1978 and 1983. Trending due to the length
of time transplantation programs existed may have been
diminished since Stanford, which has the largest number of
patients who are referred and undergo transplantation in any
year, was an already well established program by 1978, and
other programs (for example, Arizona and Pittsburgh) only
began after 1980.
Finally, Table 2 shows the proportion of patients
undergoing transplantation. Of all patients accepted across
all centers, 71.9% eventually underwent the procedure. Ac-
cepted patients were most likely to undergo the procedure
at Arizona (82.1%) and least likely to do so at Columbia
(50%). This undoubtedly reflects a poorer overall donor
situation in the New York area . If all patient referrals are
considered, it is evident that Pittsburgh has the highest rate
of transplantation (52%), and Stanford the lowest (19%).
Overall, nearly one quarter of all patient s referred for cardiac
transplantation undergo the procedure.
Discussion
Based on data presented here, it is apparent that both
Stanford and the Medical College of Virginia accept the
smallest percentage of patients referred for cardiac trans-
plantation (about 26%), whereas Columbia and Pittsburgh
are most likely to accept referred patients. Arizona accepts
about half of all referrals. Once accepted, however, there
is no guarantee that the patient will receive a transplant.
For example, although Columbia accepts a large percentage
Transplantation Center
University of Arizona
Columbi a University
Medical College of Virginia
University of Pittsburgh
Stanford University
Total
Patients Without
Contraindications
(no .)
38
24
34
48
115
259
Patients With
Contraindications
(no.)
1
I
I
I
II
15
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would seem prudent to retain fairly strict patient selection
criteria and thereb y minimize the disillusionment many po-
tential heart transplantation candidates feel while awaiting
a donor heart , and, more importantly, ensure that patient
outcome will not be adversely affected ,
Implications. Finally, it seems reasonable that the total
number of cardiac transplantation centers bear some relation
to the optim al use of the available supply of donor hearts,
when optimal use is defined as 2 1 to 24 cardiac transplan-
tations per center per year (29) . With respect to this final
point , it is noteworthy that the National Task Force on Organ
Transpl antation as well as the Ad Hoc Committee on Criteria
for Designation of Transplantation Centers of the American
Society of Transplant Surgeons have both recommended that
cardiac transplantation programs meet a very strict set of
requirements concerning annual volume, performance stan-
dards (that is, I year patient survival), as well as facility
and personnel qualifications (30) .
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